6Z3G

Repulsive Guidance Molecule A (RGMA) in complex with Growth Differentiation Factor 5 (GDF5)

Summary for 6Z3G

• Entry DOI: 10.2210/pdb6z3g/pdb
• Descriptor: Growth/differentiation factor 5, Repulsive guidance molecule A, CITRIC ACID (3 entities in total)
• Functional Keywords: repulsive guidance molecule, rgm, bone morphogenetic protein, bmp, growth differentiation factor 5, gdf5, neogenin, axon guidance, tgfbeta signalling, brain development, iron metabolism., signaling protein
• Biological source: Homo sapiens (Human); More
• Total number of polymer chains: 2
• Total formula weight: 25226.44

Authors

Malinauskas, T.,Peer, T.V.,Bishop, B.,Muller, T.D.,Siebold, C. (deposition date: 2020-05-20, release date: 2020-07-01, Last modification date: 2024-11-13)

Primary citation

Malinauskas, T.,Peer, T.V.,Bishop, B.,Mueller, T.D.,Siebold, C.
Repulsive guidance molecules lock growth differentiation factor 5 in an inhibitory complex.
Proc.Natl.Acad.Sci.USA, 117:15620-15631, 2020

PubMed Abstract: Repulsive guidance molecules (RGMs) are cell surface proteins that regulate the development and homeostasis of many tissues and organs, including the nervous, skeletal, and immune systems. They control fundamental biological processes, such as migration and differentiation by direct interaction with the Neogenin (NEO1) receptor and function as coreceptors for the bone morphogenetic protein (BMP)/growth differentiation factor (GDF) family. We determined crystal structures of all three human RGM family members in complex with GDF5, as well as the ternary NEO1-RGMB-GDF5 assembly. Surprisingly, we show that all three RGMs inhibit GDF5 signaling, which is in stark contrast to RGM-mediated enhancement of signaling observed for other BMPs, like BMP2. Despite their opposite effect on GDF5 signaling, RGMs occupy the BMP type 1 receptor binding site similar to the observed interactions in RGM-BMP2 complexes. In the NEO1-RGMB-GDF5 complex, RGMB physically bridges NEO1 and GDF5, suggesting cross-talk between the GDF5 and NEO1 signaling pathways. Our crystal structures, combined with structure-guided mutagenesis of RGMs and BMP ligands, binding studies, and cellular assays suggest that RGMs inhibit GDF5 signaling by competing with GDF5 type 1 receptors. While our crystal structure analysis and in vitro binding data initially pointed towards a simple competition mechanism between RGMs and type 1 receptors as a possible basis for RGM-mediated GDF5 inhibition, further experiments utilizing BMP2-mimicking GDF5 variants clearly indicate a more complex mechanism that explains how RGMs can act as a functionality-changing switch for two structurally and biochemically similar signaling molecules.

PubMed: 32576689
DOI: 10.1073/pnas.2000561117

Experimental method

X-RAY DIFFRACTION (2.78 Å)